Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05339581Not ApplicableUnknown
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
Hepatocellular CarcinomaLiver CancerLiver Transplant; Complications+2 more
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiu-mei Ma, MD

Dept. Radiotherapy, Renji Hospital, School of Medicine, SJTU

Similar
1 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of LiverLiver Transplant; Complications+2 more

Worked with same sponsors:

RenJi Hospital
Collaborated on 1 trial
Similarity Score54%

Qiang Xia, MD, Ph.D

Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU

Similar
1 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of LiverLiver Transplant; Complications+2 more

Worked with same sponsors:

RenJi Hospital
Collaborated on 1 trial
Similarity Score54%

Yong-rui Bai, MD

Dept. Radiotherapy, Renji Hospital, School of Medicine, SJTU

Similar
1 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of LiverLiver Transplant; Complications+2 more

Worked with same sponsors:

RenJi Hospital
Collaborated on 1 trial
Similarity Score54%

Xiao-hang Wang, MD

Dept. Radiotherapy, Renji Hospital, School of Medicine, SJTU

Similar
1 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of LiverLiver Transplant; Complications+2 more

Worked with same sponsors:

RenJi Hospital
Collaborated on 1 trial
Similarity Score54%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of Liver
Similarity Score12%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Cancer of LiverCarcinoma, Hepatocellular
Similarity Score12%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of Liver
Similarity Score12%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of Liver
Similarity Score12%

Gao-Jun Teng, MD

Zhongda Hospital

Related
14 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of Liver
Similarity Score12%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of LiverCarcinoma, Hepatocellular
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05339581Not ApplicablePrincipalInvestigator

IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation

Hepatocellular CarcinomaLiver CancerLiver Transplant; Complications+2 more
Unknown

All 1 trials loaded